| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Pathology,* Molecular and Cellular Physiology, and Cardiology, Louisiana State University Health Sciences Center–Shreveport, Shreveport, Louisiana; and Attenuon, San Diego, California
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the intestinal tract with unknown multifactorial etiology that, among other things, result in alteration and dysfunction of the intestinal microvasculature. Clinical observations of increased colon microvascular density during IBD have been made. However, there have been no reports investigating the physiological or pathological importance of angiogenic stimulation during the development of intestinal inflammation. Here we report that the dextran sodium sulfate and CD4+CD45RBhigh T-cell transfer models of colitis stimulate angiogenesis that results in increased blood vessel density concomitant with increased histopathology, suggesting that the neovasculature contributes to tissue damage during colitis. We also show that leukocyte infiltration is an obligatory requirement for the stimulation of angiogenesis. The angiogenic response during experimental colitis was differentially regulated in that the production of various angiogenic mediators was diverse between the two models with only a small group of molecules being similarly controlled. Importantly, treatment with the anti-angiogenic agent thalidomide or ATN-161 significantly reduced angiogenic activity and associated tissue histopathology during experimental colitis. Our findings identify a direct pathological link between angiogenesis and the development of experimental colitis, representing a novel therapeutic target for IBD.
This article has been cited by other articles:
 |
|
 |
|
  Md. M. Aziz, S. Ishihara, Y. Mishima, N. Oshima, I. Moriyama, T. Yuki, Y. Kadowaki, M. A. K. Rumi, Y. Amano, and Y. Kinoshita MFG-E8 Attenuates Intestinal Inflammation in Murine Experimental Colitis by Modulating Osteopontin-Dependent {alpha}v{beta}3 Integrin Signaling J. Immunol., June 1, 2009; 182(11): 7222 - 7232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Harris, J. R. Whatley, P. R. Carter, G. A. Morgan, and M. B. Grisham Altered microvascular hemodynamics during the induction and perpetuation of chronic gut inflammation Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G750 - G754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tolstanova, T. Khomenko, X. Deng, L. Chen, A. Tarnawski, A. Ahluwalia, S. Szabo, and Z. Sandor Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 749 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Neshat, M. deVries, A. R. Barajas-Espinosa, L. Skeith, S. P. Chisholm, and A. E. Lomax Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39 Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G399 - G405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Deban, C. Correale, S. Vetrano, A. Malesci, and S. Danese Multiple Pathogenic Roles of Microvasculature in Inflammatory Bowel Disease: A Jack of All Trades Am. J. Pathol., June 1, 2008; 172(6): 1457 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Donate, G. C. Parry, Y. Shaked, H. Hensley, X. Guan, I. Beck, Z. Tel-Tsur, M. L. Plunkett, M. Manuia, D. E. Shaw, et al. Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth Clin. Cancer Res., April 1, 2008; 14(7): 2137 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Senthilkumar, R. D. Smith, J. Khitha, N. Arora, S. Veerareddy, W. Langston, J. H. Chidlow Jr, S. C. Barlow, X. Teng, R. P. Patel, et al. Sildenafil Promotes Ischemia-Induced Angiogenesis Through a PKG-Dependent Pathway Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1947 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Chidlow Jr., D. Shukla, M. B. Grisham, and C. G. Kevil Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G5 - G18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Danese, M. Sans, D. M Spencer, I. Beck, F. Donate, M. L Plunkett, C. de la Motte, R. Redline, D. E Shaw, A. D Levine, et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis Gut, June 1, 2007; 56(6): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
